Strange: Bullish BIO Analysts Actually See -12.97% Downside
November 09, 2020 at 08:37 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Bio-Rad Laboratories Inc (BIO). The average 12-month price target for BIO — averaging the work of 4 analysts — reveals an average price target of $560.00/share..